R. Kent McGaughy's Insider Trades & SAST Disclosures
R. Kent McGaughy's most recent trade in Instil Bio Inc was a trade of 5,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern R. Kent McGaughy.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Instil Bio Inc | R. Kent McGaughy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Instil Bio Inc | McGaughy R. Kent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 1,500 | 1,500 | - | - | Stock Option (Right to Buy) | |
| Reata Pharmaceuticals Inc ... | R. Kent McGaughy | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 4,275 | 4,275 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | R. Kent McGaughy | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 1,628 | 1,628 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | R. Kent McGaughy | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Mar 2023 | 33,217 | 0 (0%) | 0% | 0 | Class A common stock | |
| Reata Pharmaceuticals Inc ... | R. Kent McGaughy | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 11,240 | 11,240 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | R. Kent McGaughy | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 4,787 | 4,787 | - | - | Stock Option (right to buy) | |
| Instil Bio Inc | R. Kent McGaughy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Instil Bio Inc | R. Kent McGaughy | Director | Other type of transaction at price $ 0.00 per share. | 15 Mar 2022 | 260,323 | 8,218,467 | - | 0 | Common Stock | |
| Reata Pharmaceuticals Inc ... | R. Kent McGaughy | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 399 | 399 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | R. Kent McGaughy | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | R. Kent McGaughy | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 690 | 690 | - | - | Stock Option (right to buy) | |
| Instil Bio Inc | R. Kent McGaughy | Director | 23 Mar 2021 | 7,074,608 | 7,074,608 | - | - | Common Stock | ||
| Instil Bio Inc | R. Kent McGaughy | Director | 23 Mar 2021 | 5,895,507 | 0 | - | - | Series B Preferred Stock | ||
| Instil Bio Inc | R. Kent McGaughy | Director | 23 Mar 2021 | 954,182 | 8,028,790 | - | - | Common Stock | ||
| Instil Bio Inc | R. Kent McGaughy | Director | 23 Mar 2021 | 795,152 | 0 | - | - | Series C Preferred Stock | ||
| Instil Bio Inc | R. Kent McGaughy | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 23 Mar 2021 | 450,000 | 8,478,790 | - | 20 | 9,000,000 | Common Stock |
| Instil Bio Inc | R. Kent McGaughy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2021 | 52,000 | 52,000 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | R. Kent McGaughy | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 23 Dec 2020 | 166,666 | 2,896,901 (10%) | 0% | - | Class A common stock | |
| Reata Pharmaceuticals Inc ... | R. Kent McGaughy | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 6,300 | 6,300 | - | - | Stock Option (right to buy) | |
| Reata Pharmaceuticals Inc ... | R. Kent McGaughy | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 699 | 699 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges